Omega-3 dosage and evidence

What is Omega-3?

How does Omega-3 work?

EPA and DHA are the two main omega-3 fats in fish oil. They build into the outer wall of your cells. There they push out another fat, arachidonic acid, that feeds swelling signals. They are also made into molecules that help switch swelling off once its job is done. EPA makes the liver produce less triglyceride, a blood fat. That is why high-dose prescription versions are used for very high triglycerides. DHA is a main building block of the eye and brain. The same changes to cell walls also change how heart cells fire. That is the most likely reason for the irregular heartbeat finding.

What have studies in people found about Omega-3?

A very large set of human studies, with results that depend on the dose and the product. At normal supplement doses in ordinary people, the big studies found nothing. At prescription doses in high-risk patients, one study was strongly positive and one found nothing.

• The VITAL study gave 25,871 ordinary adults 1 gram a day or a dummy pill. It did not lower heart attacks or strokes.
• The REDUCE-IT study gave 8,179 high-risk patients on a statin 4 grams a day of a purified fish oil drug (icosapent ethyl). They had far fewer heart attacks, strokes and heart deaths. The comparison group took mineral oil, and that choice is disputed.
• The STRENGTH study tested a high dose in a similar group, with corn oil for comparison. It found nothing and was stopped early.
• Across 17 studies that just watched people, those with the most omega-3 in their blood had about 15 to 18% lower death rates than those with the least.
• In VITAL, people on omega-3 got atrial fibrillation (an irregular heartbeat) more often. Across other studies, the risk rises with each extra gram a day.
• Most people in Western countries have an omega-3 index well below the 8 to 10% often named as a target. That is the practical case for taking it if you do not eat oily fish.

What this does not tell you: The central fight is not settled, and this page does not settle it. Critics of REDUCE-IT say the mineral oil raised LDL (bad) cholesterol and swelling markers in the comparison group. That would make the drug look better than it is. The published defence of the mineral oil appeared in a journal add-on paid for by the drug's maker, with one of the maker's people as an author. The study's lead author also chaired the maker's safety monitoring board. Also note what does not carry over. Four grams of a purified prescription EPA is not a fish oil capsule. A good result in high-risk patients on statins does not apply to a healthy person.

What do people who took Omega-3 report?

This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.

• The interesting part of the discussion is the top end. People describe intakes far above the usual couple of grams, into the tens of grams a day, and whether that is sensible is argued out rather than settled.
• Adverse reports cluster at those high intakes and include headache, dizziness, mental cloudiness, sore eyes and trouble focusing them, irritability, low mood and reduced libido. The same people describe the problems easing when they dropped back toward a gram a day.
• The explanations offered in the threads for those effects are vasodilation, oxidative load from a large polyunsaturated intake without matching antioxidants, and escalating too quickly, rather than the fats themselves.
• Bleeding is the negative raised most seriously, described as thinner blood and slower wound healing, and there are threads from people who stopped for that reason. Others counter with work showing platelet aggregation falling without bleeding time changing, so its practical significance is disputed inside the same threads.
• Palpitations over several years of use appear as an individual account rather than a pattern.
• Product quality and rancidity are a constant background argument, with the other fats in a given product and its oxidation state blamed for symptoms as often as the omega-3 content is.

Sources: High dose fish oil, supplement and mental health threads on LongeCity, found by site-restricted search and read directly, September 2026. Nothing above is attributed to any specific post and no post is reproduced.

The state of the research

The evidence, in charts

The studies we cite

• Study in people2019
  Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia

  A purified fish oil drug cut heart attacks and strokes in people already on a statin, and the result is disputed. Over eight thousand patients with high triglycerides took either a high dose of icosapent ethyl or a comparison oil every day. The treated group had markedly fewer heart attacks, strokes and cardiac deaths. Here is the problem. The comparison oil was mineral oil, and mineral oil may have made the comparison group look worse than they should have. That argument is unresolved.

  REDUCE-IT. 8,179 statin-treated patients with raised triglycerides randomised to 4 g of icosapent ethyl daily or a mineral oil placebo. A large reduction in major cardiovascular events. The positive half of the dispute, and the placebo is the contested part.

  PMID 30415628 New England Journal of Medicine
• Study in people2020
  Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk (STRENGTH)

  The same idea was tested against a different comparison oil and it did not work. A high dose of omega-3 was given to a similar group of high-risk patients already taking a statin. The comparison group got corn oil instead of mineral oil. There was no reduction in heart attacks, strokes or cardiac deaths. The trial was stopped early because it was clear it would not show a benefit. Put beside the trial above, this is why the fish oil question is still argued over.

  The null half. A high-dose omega-3 against a corn oil placebo in a comparable high-risk statin-treated population produced no reduction in major adverse cardiovascular events. The trial was stopped for futility.

  PMID 33190147 JAMA
• Study in people2021
  Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies

  People with more omega-3 in their blood died less often, but nobody was given anything. Researchers pooled seventeen studies that simply followed people over time and measured what was already in their blood. Those in the top fifth for blood omega-3 had roughly 15 to 18 percent lower death rates than those in the bottom fifth. This was watching, not testing. Nobody was assigned a supplement. A blood level reflects diet, wealth and general health at once, so it cannot tell you what a capsule would do.

  Pooled across 17 prospective cohorts. The highest blood omega-3 quintile carried roughly 15 to 18% lower mortality than the lowest. Observational, and the exposure is a measured blood level rather than a supplement taken.

  PMID 33888689 Nature Communications
• Study in people2021
  Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation

  Omega-3 raised the risk of an irregular heartbeat, and this is the safety signal that matters. Inside the same very large vitamin D trial, a planned analysis looked at a daily gram of marine omega-3. People on omega-3 developed atrial fibrillation more often than those on the dummy. Atrial fibrillation is a fast, irregular heart rhythm that raises stroke risk. Across the wider body of trials, the higher the dose, the stronger this signal gets. It is the clearest harm attached to fish oil.

  VITAL-RHYTHM, the prespecified atrial fibrillation analysis inside the 25,871-participant VITAL trial. Omega-3 was associated with increased incident atrial fibrillation. Across the wider randomised literature the signal rises with dose.

  PMID 33724323 JAMA
• Study in people2019
  Vitamin D supplements and prevention of cancer and cardiovascular disease

  At the dose most people actually swallow, fish oil did not protect the heart. The same huge trial also assigned about 26,000 general-population adults to one gram of marine omega-3 a day or a dummy. The main heart question it was built to answer came out empty. That is the answer for ordinary people buying ordinary capsules. The drug trials above used four times that dose in patients already at high risk. Do not read a result from those trials onto a supermarket supplement.

  VITAL also randomised 1 g a day of marine omega-3 in the same 25,871 participants. That arm missed its primary cardiovascular endpoint too, which is the general-population answer at a supplement-level dose.

  PMID 30415629 New England Journal of Medicine